Ocuris Pharmaceuticals Private Limited

Ocuris Pharmaceuticals Private Limited - pharma in Gurgaon, Haryana, India. FY 2026 financials & compliance.
CIN U74999HR2017PTC068224 Incorporated 20 March 2017 ROC Delhi HQ Gurgaon, Haryana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2021
₹46.98 Lakh
▲ 12% YoY
Net profit · FY 2021
₹1.32 Lakh
Net margin 2.8%
EBITDA · FY 2021
₹2.74 Lakh
EBITDA margin 5.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹25 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings

About Ocuris Pharmaceuticals Private Limited

Data last updated:

Ocuris Pharmaceuticals Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 March 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999HR2017PTC068224. Its GSTIN is 06AACCO4666P1ZV (Haryana).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mahavir Singh Nahar and Neetu.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 4 Ashok Vihar Phase – II Palam Vihar Road, Gurgaon, Haryana, India – 122001.

As per the financials filed for FY 2021, the company reported a revenue of ₹46.98 Lakh, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹1.32 Lakh (net margin 2.8%) and EBITDA of ₹2.74 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years.

As per MCA filings, the company has open charges of ₹25 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.

Ocuris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0020359). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ocuris.in.

Company details

CIN U74999HR2017PTC068224
Registration Number 068224
Incorporation Date 20 March 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-05-0020359
Key People
Mahavir Singh Nahar Director Neetu Director Nirdosh Nahar Director

Recognitions & Rankings of Ocuris Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-HR-05-0020359

Contact details

Ocuris Pharmaceuticals Private Limited's registered office is in Gurgaon, Haryana. Its website is ocuris.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    ocuris.in
  • Registered Address
    Shop No. 4 Ashok Vihar Phase – II Palam Vihar Road, Gurgaon, Haryana, India – 122001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Ocuris Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Ocuris Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ocuris Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Ocuris Pharmaceuticals Private Limited, buy the company report.

Financials of Ocuris Pharmaceuticals Private Limited

FY 2025 filings available

Ocuris Pharmaceuticals Private Limited reported revenue of ₹46.98 Lakh (up 12% YoY) for FY 2021.

Revenue · FY 2021
₹46.98 Lakh ▲ 12%
Net profit · FY 2021
₹1.32 Lakh margin 2.8%
EBITDA · FY 2021
₹2.74 Lakh margin 5.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 37%
EBITDA CAGR growth
1 year
▲ 144%
3 years · compounded
▲ 103%

Revenue has grown at a compounded annual rate (CAGR) of 37% over three years, including 12% growth in the latest year. EBITDA rose 144% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹46.98 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.74 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.32 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin5.8%
Net Profit Margin2.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ocuris Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ocuris Pharmaceuticals Private Limited

Ocuris Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Mahavir Singh NaharDirector20 Mar 20179 Years 7 MonthsCurrent
NeetuDirector20 Mar 20179 Years 7 MonthsCurrent
Nirdosh Nahar
Also directs: JN Healthcare LLP
Director20 Mar 20179 Years 7 MonthsCurrent
View all directors

Peer comparison

Ocuris Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
RDW Pharmaceuticals Private Limited₹47.05 Lakh (FY 2024)15.0%Mumbai, Maharashtra, India
Alkyd Pharmaceuticals Private Limited₹47.01 Lakh (FY 2023)-32.0%Dhanbad, Jharkhand, India
Ocuris Pharmaceuticals Private Limitedthis company₹46.98 Lakh (FY 2021)₹1.32 Lakh2.8%12.0%Gurgaon, Haryana, India
Arvaya Healthcare Limited₹46.87 Lakh (FY 2025)-20.0%Gmc, Assam, India
Raciwell Pharma Private Limited₹46.82 Lakh (FY 2023)-55.0%Mumbai, Maharashtra, India

To see the full peer comparison of Ocuris Pharmaceuticals Private Limited, buy the company report.

Auditor

Ocuris Pharmaceuticals Private Limited is audited by SHANKAR SOLANKI & ASSOCIATES for the financial year 2021.

Auditor firmFinancial yearFirm registration number
SHANKAR SOLANKI & ASSOCIATESFY 2021025827N

Shareholding

The shareholding of Ocuris Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Ocuris Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹25 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.25 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Apr 2022100578477Others₹25 LakhOpen

To see the full charge records of Ocuris Pharmaceuticals Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ocuris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ocuris Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AACCO4666P1ZVHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Ocuris Pharmaceuticals Private Limited, buy the company report.

Recent activity

Ocuris Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Mahavir Singh Nahar was appointed as Director on 20 Mar 2017.

AGM
Ocuris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ocuris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others of Rs. 25.00 Lakh registered on 30 Apr 2022 with Charge ID 100578477 was modified on 16 Oct 2024.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 100578477 was registered on 30 Apr 2022.
Appointed
Mahavir Singh Nahar was appointed as Director.
Appointed
Neetu was appointed as Director.
Appointed
Nirdosh Nahar was appointed as Director.
Incorporation
20 Mar 2017
Ocuris Pharmaceuticals Private Limited was registered on 20 Mar 2017 with Roc Delhi & aged 9 years 7 months as per MCA records.

Frequently asked questions

Ocuris Pharmaceuticals is an active private limited company based in Gurgaon, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 March 2017 (9+ years old) and is registered under CIN U74999HR2017PTC068224.

Ocuris Pharmaceuticals has 3 current directors:

The latest financial statements of Ocuris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Ocuris Pharmaceuticals is 06AACCO4666P1ZV, registered in Haryana.

The CIN (Corporate Identification Number) of Ocuris Pharmaceuticals is U74999HR2017PTC068224. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ocuris Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.

Ocuris Pharmaceuticals was incorporated on 20 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Ocuris Pharmaceuticals by revenue are RDW Pharmaceuticals Private Limited, Alkyd Pharmaceuticals Private Limited, Arvaya Healthcare Limited, Raciwell Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Mahavir Singh Nahar was appointed as Director on 20 Mar 2017. Neetu was appointed as Director on 20 Mar 2017. Nirdosh Nahar was appointed as Director on 20 Mar 2017.

Yes, Ocuris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0020359).

Ocuris Pharmaceuticals can be reached through the website ocuris.in. Its registered office is in Gurgaon, Haryana, India.